Research Output per year
Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Hematologic Malignancies is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Cyclin-Dependent Kinases
Medicine & Life Sciences
Lymphoma
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia
Medicine & Life Sciences
Hodgkin Disease
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Hereditary Hemorrhagic Telangiectasia
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Rajat Bannerji
- Cancer Institute of New Jersey (CINJ), Hematologic Malignancies - ASSOC PROF-CLIN-DIV CHIEF
- Clinical Investigations and Precision Therapeutics Program, CINJ - ASSOCIATE MEMBER
Person
Kevin David
- Cancer Institute of New Jersey (CINJ), Hematologic Malignancies - ASST PROF-PROF PRAC
Person
Athena Kritharis
- Cancer Institute of New Jersey (CINJ), Hematologic Malignancies - ASST PROF-PROF PRAC
Person
Research Output 1990 2019
Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma
David, K. & Evens, A. M., Jan 1 2019, (Accepted/In press) In : Leukemia.Research output: Contribution to journal › Article
Cell- and Tissue-Based Therapy
Natural Killer Cells
Non-Hodgkin's Lymphoma
Lymphoma
Cell Line
Management of older Hodgkin lymphoma patients
Evens, A. M. & David, K. A., Dec 6 2019, In : Hematology (United States). 2019, 1, p. 233-242 10 p.Research output: Contribution to journal › Article
Open Access
Hodgkin Disease
Dacarbazine
Bleomycin
Doxorubicin
Therapeutics
5
Citations
(Scopus)
Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia
Kritharis, A., Feb 1 2019, In : Journal of Internal Medicine. 285, 2, p. 223-231 9 p.Research output: Contribution to journal › Article
Hereditary Hemorrhagic Telangiectasia
Hemorrhage
Epistaxis
Hemoglobins
Therapeutics
Press/Media
Combination immune therapy shows promise against Hodgkin lymphoma 6 Dec 2016
12/6/16
9 items of Media coverage
Press/Media: Press / Media
Appointments, Resignations, Deaths (1/15/2016)
1/10/16
1 item of Media coverage
Press/Media: Press / Media